Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical Investigation
J Clin Invest. 1987 July; 80(1): 33–40.
PMCID: PMC442198

Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.


Mechanisms of thrombocytopenia were studied in 38 patients with mild to moderately severe chronic autoimmune thrombocytopenia (AITP). 51Cr and 111In-labeled autologous platelet turnover studies and in vitro analysis of committed megakaryocyte progenitors (CFU-Meg) were used as independent measures of platelet production. Autologous 111In-labeled platelet localization studies were performed to assess platelet clearance. Although there was no increase in the frequency of marrow CFU-Meg, a specific increase in the CFU-Meg [3H]TdR suicide rate was seen which was inversely correlated with the platelet count (P less than 0.001). Platelet turnover studies showed significant numbers of patients had inappropriate thrombopoietic responses to their reduced platelet counts. Platelet-associated antibody levels correlated inversely with platelet turnover suggesting that antiplatelet antibody impairs platelet production. The circulating platelet count was best predicted by an index relating platelet production (i.e., turnover) to the spleen-liver platelet clearance that correlated directly with platelet survival (P less than 0.001). In summary, both depressed platelet production and increased platelet clearance by the liver and spleen contribute to the thrombocytopenia of AITP.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • McMillan R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med. 1981 May 7;304(19):1135–1147. [PubMed]
  • Kelton JG, Gibbons S. Autoimmune platelet destruction: idiopathic thrombocytopenic purpura. Semin Thromb Hemost. 1982 Apr;8(2):83–104. [PubMed]
  • Karpatkin S. Autoimmune thrombocytopenic purpura. Blood. 1980 Sep;56(3):329–343. [PubMed]
  • Branehög I, Kutti J, Weinfeld A. Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP). Br J Haematol. 1974 May;27(1):127–143. [PubMed]
  • Harker LA. Thrombokinetics in idiopathic thrombocytopenic purpura. Br J Haematol. 1970 Jul;19(1):95–104. [PubMed]
  • Branehög I. Platelet kinetics in idiopathic thrombocytopenic purpura (ITP) before and at different times after splenectomy. Br J Haematol. 1975 Mar;29(3):413–426. [PubMed]
  • Baldini M. Idiopathic thrombocytopenic purpura. N Engl J Med. 1966 Jun 2;274(22):1245–contd. [PubMed]
  • Aster RH, Keene WR. Sites of platelet destruction in idiopathic thrombocytopenic purpura. Br J Haematol. 1969 Jan-Feb;16(1):61–73. [PubMed]
  • COHEN P, GARDNER FH, BARNETT GO. Reclassification of the thrombocytopenias by the Cr51-labeling method for measuring platelet life span. N Engl J Med. 1961 Jun 22;264:1294–contd. [PubMed]
  • PISCIOTTA AV, STEFANINI M, DAMESHEK W. Studies on platelets. X. Morphologic characteristics of megakaryocytes by phase contrast microscopy in normals and in patients with idiopathic thrombocytopenic purpura. Blood. 1953 Aug;8(8):703–723. [PubMed]
  • ROBSON HN. Idiopathic thrombocytopenic purpura. Q J Med. 1949 Oct;18(72):279–297. [PubMed]
  • Heyns AD, Lötter MG, Badenhorst PN, de Kock F, Pieters H, Herbst C, van Reenen OR, Kotze H, Minnaar PC. Kinetics and sites of destruction of 111Indium-oxine-labeled platelets in idiopathic thrombocytopenic purpura: a quantitative study. Am J Hematol. 1982 Apr;12(2):167–177. [PubMed]
  • Grossi A, Vannucchi AM, Casprini P, Guidi S, Rafanelli D, Pecchioli MG, Rossi Ferrini P. Different patterns of platelet turnover in chronic idiopathic thrombocytopenic purpura. Scand J Haematol. 1983 Sep;31(3):206–214. [PubMed]
  • Schmidt KG, Rasmussen JW. Kinetics and distribution in vivo of 111In-labelled autologous platelets in idiopathic thrombocytopenic purpura. Scand J Haematol. 1985 Jan;34(1):47–56. [PubMed]
  • Stoll D, Cines DB, Aster RH, Murphy S. Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood. 1985 Mar;65(3):584–588. [PubMed]
  • Mazur EM, Hoffman R, Chasis J, Marchesi S, Bruno E. Immunofluorescent identification of human megakaryocyte colonies using an antiplatelet glycoprotein antiserum. Blood. 1981 Feb;57(2):277–286. [PubMed]
  • Thiagarajan P, Perussia B, De Marco L, Wells K, Trinchieri G. Membrane proteins on human megakaryocytes and platelets identified by monoclonal antibodies. Am J Hematol. 1983 May;14(3):255–269. [PubMed]
  • McMillan R, Luiken GA, Levy R, Yelenosky R, Longmire RL. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA. 1978 Jun 9;239(23):2460–2462. [PubMed]
  • Cines DB, Schreiber AD. Immune thrombocytopenia. Use of a Coombs antiglobulin test to detect IgG and C3 on platelets. N Engl J Med. 1979 Jan 18;300(3):106–111. [PubMed]
  • Cuatrecasas P. Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads. J Biol Chem. 1970 Jun;245(12):3059–3065. [PubMed]
  • NISONOFF A, WISSLER FC, LIPMAN LN, WOERNLEY DL. Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds. Arch Biochem Biophys. 1960 Aug;89:230–244. [PubMed]
  • Slichter SJ. Post-transfusion purpura: response to steroids and association with red blood cell and lymphocytotoxic antibodies. Br J Haematol. 1982 Apr;50(4):599–605. [PubMed]
  • Tangen O, Berman HJ, Marfey P. Gel filtration. A new technique for separation of blood platelets from plasma. Thromb Diath Haemorrh. 1971 Jun 30;25(2):268–278. [PubMed]
  • Kimura H, Burstein SA, Thorning D, Powell JS, Harker LA, Fialkow PJ, Adamson JW. Human megakaryocytic progenitors (CFU-M) assayed in methylcellulose: physical characteristics and requirements for growth. J Cell Physiol. 1984 Jan;118(1):87–96. [PubMed]
  • Powell JS, Fialkow PJ, Adamson JW. Polycythemia vera: studies of hemopoiesis in continuous long-term culture of human marrow. J Cell Physiol Suppl. 1982;1:79–85. [PubMed]
  • Burstein SA, Adamson JW, Thorning D, Harker LA. Characteristics of murine megakaryocytic colonies in vitro. Blood. 1979 Jul;54(1):169–179. [PubMed]
  • Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest. 1969 Jun;48(6):963–974. [PMC free article] [PubMed]
  • Thakur ML, Welch MJ, Joist JH, Coleman RE. Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. Thromb Res. 1976 Oct;9(4):345–357. [PubMed]
  • Stratton JR, Ritchie JL, Hamilton GW, Hammermeister KE, Harker LA. Left ventricular thrombi: in vivo detection by indium-111 platelet imaging and two dimensional echocardiography. Am J Cardiol. 1981 Apr;47(4):874–881. [PubMed]
  • Murphy EA, Francis ME. The estimation of blood platelet survival. II. The multiple hit model. Thromb Diath Haemorrh. 1971;25(1):53–80. [PubMed]
  • Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood. 1985 Nov;66(5):1105–1109. [PubMed]
  • van Reenen PC, Lötter MG, Heyns AD, de Kock F, Herbst C, Kotzé H, Pieters H, Minnaar PC, Badenhorst PN. Quantification of the distribution of 111In-labelled platelets in organs. Eur J Nucl Med. 1982;7(2):80–84. [PubMed]
  • Burstein SA, Erb SK, Adamson JW, Harker LA. Immunologic stimulation of early murine hematopoiesis and its abrogation by cyclosporin A. Blood. 1982 Apr;59(4):851–856. [PubMed]
  • Levin J, Levin FC, Metcalf D. The effects of acute thrombocytopenia on megakaryocyte-CFC and granulocyte-macrophage-CFC in mice: studies of bone marrow and spleen. Blood. 1980 Aug;56(2):274–283. [PubMed]
  • Burstein SA, Adamson JW, Erb SK, Harker LA. Megakaryocytopoiesis in the mouse: response to varying platelet demand. J Cell Physiol. 1981 Nov;109(2):333–341. [PubMed]
  • Kimura H, Segal GM, Lee MY, Adamson JW. Megakaryocytopoiesis in the rat: response to thrombocytopenia induced by exchange transfusion. Exp Hematol. 1985 Nov;13(10):1048–1054. [PubMed]
  • Long MW, Gragowski LL, Heffner CH, Boxer LA. Phorbol diesters stimulate the development of an early murine progenitor cell. The burst-forming unit-megakaryocyte. J Clin Invest. 1985 Aug;76(2):431–438. [PMC free article] [PubMed]
  • Paulus JM, Prenant M, Deschamps JF, Henry-Amar M. Polyploid megakaryocytes develop randomly from a multicompartmental system of committed progenitors. Proc Natl Acad Sci U S A. 1982 Jul;79(14):4410–4414. [PubMed]
  • Williams N, Jackson H. Regulation of proliferation of murine megakaryocyte progenitor cells by cell cycle. Blood. 1978 Jul;52(1):163–170. [PubMed]
  • Branehög I, Kutti J, Ridell B, Swolin B, Weinfeld A. The relation of thrombokinetics to bone marrow megakaryocytes in idiopathic thrombocytopenic purpura (ITP). Blood. 1975 Apr;45(4):551–562. [PubMed]
  • Heyns A du P, Badenhorst PN, Lötter MG, Pieters H, Wessels P, Kotzé HF. Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ. Blood. 1986 Jan;67(1):86–92. [PubMed]
  • Abrahamsen AF. Survival of 51Cr-labelled autologous and isologous platelets as differential diagnostic aid in thrombocytopenic states. Scand J Haematol. 1970;7(6):525–528. [PubMed]
  • GASSER C. Pure red cell anemia due to auto antibodies; immune-type of aplastic anemia, erythroblastopenia. Sang. 1955;26(1):6–13. [PubMed]
  • McMillan R, Longmire RL, Yelenosky R, Smith RS, Craddock CG. Immunoglobulin synthesis in vitro by splenic tissue in idiopathic thrombocytopenic purpura. N Engl J Med. 1972 Mar 30;286(13):681–684. [PubMed]
  • Karpatkin S, Strick N, Siskind GW. Detection of splenic anti-platelet antibody synthesis in idiopathic autoimmune thrombocytopenic purpura (ATP). Br J Haematol. 1972 Aug;23(2):167–176. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation